Morgan Stanley boosted its position in Boston Scientific shares, while the company's board authorized a stock repurchase program.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley boosted its position in Boston Scientific shares, while the company's board authorized a stock repurchase program.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Morgan Stanley
U.S. investment bank
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
Related events
- Norges Bank purchased a new position in shares of Boston Scientific.
- Multiple financial firms, including BlackRock, UBS AM, and Legal & General Group Plc, bought new stakes in JBG SMITH Properties stock.
- Morgan Stanley and Geode Capital Management acquired positions in SoFi shares, concurrent with insider sales disclosures to the SEC.
- Multiple financial institutions, including Morgan Stanley and Norges Bank, made significant moves regarding Assurant stock, alongside analyst rating changes and SEC filings.
- Morgan Stanley, State Street Corp, and other firms increased their holdings in Quest Diagnostics during Q2, Q3, and Q4 of 2026.